Colgate-Palmolive
Market Cap
US$58.2b
Last Updated
2019/10/16 23:35 UTC
Data Sources
Company Financials +
Executive Summary
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide.
Snowflake
Fundamentals
Established dividend payer with acceptable track record.
Similar Companies
Share Price & News
How has Colgate-Palmolive's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-3.9%
CL
-3.4%
US Household Products
2.3%
US Market
1 Year Return
6.8%
CL
36.4%
US Household Products
5.6%
US Market
Return vs Industry: CL underperformed the US Household Products industry which returned 36.4% over the past year.
Return vs Market: CL exceeded the US Market which returned 5.6% over the past year.
Shareholder returns
| CL | Industry | Market | |
|---|---|---|---|
| 7 Day | -3.9% | -3.4% | 2.3% |
| 30 Day | -2.3% | -1.9% | -1.0% |
| 90 Day | -8.2% | 0.8% | -0.7% |
| 1 Year | 9.5%6.8% | 40.3%36.4% | 7.9%5.6% |
| 3 Year | 1.5%-5.4% | 46.6%35.0% | 45.6%36.3% |
| 5 Year | 15.9%3.9% | 64.3%42.2% | 65.8%47.6% |
Price Volatility Vs. Market
How volatile is Colgate-Palmolive's share price compared to the market and industry in the last 5 years?
Simply Wall St News
13 hours ago | Simply Wall St
Colgate-Palmolive Company (NYSE:CL) Pays A 0.6% In Just 4 Days1 week ago | Simply Wall St
What Kind Of Investor Owns Most Of Colgate-Palmolive Company (NYSE:CL)?3 weeks ago | Simply Wall St
Why Colgate-Palmolive Company's (NYSE:CL) High P/E Ratio Isn't Necessarily A Bad ThingValuation
Is Colgate-Palmolive undervalued compared to its fair value and its price relative to the market?
25.77x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: CL ($67.85) is trading above our estimate of fair value ($65.52)
Significantly Undervalued: CL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CL is good value based on its PE Ratio (25.8x) compared to the Household Products industry average (26.5x).
PE vs Market: CL is poor value based on its PE Ratio (25.8x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
Low PEG Ratio: CL is poor value based on its PEG Ratio (5x)
Price to Book Ratio
PB vs Industry: CL has negative assets, so we can't compare its PB Ratio to the US Household Products industry average.
Next Steps
Future Growth
How is Colgate-Palmolive forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
5.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CL's forecast earnings growth (5.2% per year) is above the savings rate (2.7%).
Earnings vs Market: CL's earnings (5.2% per year) are forecast to grow slower than the US market (14.5% per year).
High Growth Earnings: CL's earnings are forecast to grow, but not significantly.
Revenue vs Market: CL's revenue (2.5% per year) is forecast to grow slower than the US market (7.3% per year).
High Growth Revenue: CL's revenue (2.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: CL's Return on Equity is forecast to be very high in 3 years time (1729.7%).
Next Steps
Past Performance
How has Colgate-Palmolive performed over the past 5 years?
-0.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: CL's earnings have declined by -0.5% per year over the past 5 years.
Accelerating Growth: CL's earnings growth over the past year (3.4%) exceeds its 5-year average (-0.5% per year).
Earnings vs Industry: CL earnings growth over the past year (3.4%) exceeded the Household Products industry -7.1%.
Return on Equity
High ROE: CL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
ROA vs Industry: CL has a higher Return on Assets than the Household Products industry average last year.
Return on Capital Employed
ROCE Improving: CL's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Colgate-Palmolive's financial position?
Financial Position Analysis
Short Term Liabilities: CL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CL has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: CL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: CL's debt is well covered by operating cash flow (45.3%).
Interest Coverage: CL's interest payments on its debt are well covered by EBIT (23.7x coverage).
Balance Sheet
Inventory Level: CL has a high level of physical assets or inventory.
Debt Coverage by Assets: CL has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Next Steps
Dividend
What is Colgate-Palmolive's current dividend yield, its reliability and sustainability?
2.54%
Current Dividend Yield
Upcoming Dividend Payment
Purchase Colgate-Palmolive before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: CL's dividend (2.54%) is higher than the bottom 25% of dividend payers in the US market (1.46%).
High Dividend: CL's dividend (2.54%) is low compared to the top 25% of dividend payers in the US market (3.76%).
Stable Dividend: CL's dividends per share have been stable in the past 10 years.
Growing Dividend: CL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (64.2%), CL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CL's dividends in 3 years are forecast to be covered by earnings (60.5% payout ratio).
Next Steps
Management
What is the CEO of Colgate-Palmolive's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
Noel Wallace (55yo)
0.5yrs
Tenure
US$2,806,390
Compensation
Mr. Noel R. Wallace is Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. He was Chief Operating Officer of Colgate-Palmol ...
CEO Compensation Analysis
Compensation vs. Market: Noel has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.
Compensation vs Earnings: Noel's compensation has been consistent with company performance over the past year.
Management Age and Tenure
0.8yrs
Average Tenure
57yo
Average Age
Experienced Management: CL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
4.6yrs
Average Tenure
62yo
Average Age
Experienced Board: CL's board of directors are considered experienced (4.6 years average tenure).
Insider Trading
Insider Buying: CL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Shares | 714 |
| Max Price | US$71.01 |
| Entity | Individual |
| Shares | 10,170 |
| Max Price | US$71.05 |
| Entity | Individual |
| Shares | 5,000 |
| Max Price | US$69.35 |
| Entity | Individual |
| Shares | 14,039 |
| Max Price | US$71.11 |
Ownership Breakdown
Management Team
Ian Cook (66yo)
Executive Chairman
- Tenure: 10.8yrs
- Compensation: US$11.55m
Pat Verduin (60yo)
Chief Technology Officer
- Tenure: 0yrs
Noel Wallace (55yo)
President
- Tenure: 0.5yrs
- Compensation: US$2.81m
Henning Jakobsen (59yo)
Chief Financial Officer
- Tenure: 1.4yrs
- Compensation: US$2.22m
Jennifer Daniels (55yo)
Chief Legal Officer & Secretary
- Tenure: 4.9yrs
Mike Crowe
Chief Information Officer
- Tenure: 0yrs
John Faucher
Senior Vice President of Investor Relations
- Tenure: 0yrs
Paula Davis
VP & Chief Communications Officer
- Tenure: 1.2yrs
Valerie Haliburton
Vice President of Global Ethics & Compliance
- Tenure: 0.8yrs
John Kooyman (54yo)
Chief Marketing Officer
- Tenure: 0.8yrs
Board Members
Steve Sadove (67yo)
Lead Director
- Tenure: 0yrs
- Compensation: US$319.04k
Ian Cook (66yo)
Executive Chairman
- Tenure: 10.8yrs
- Compensation: US$11.55m
John Cahill (62yo)
Independent Director
- Tenure: 14yrs
- Compensation: US$303.74k
C. Harris (63yo)
Independent Director
- Tenure: 3.6yrs
- Compensation: US$290.49k
Lorrie Norrington (59yo)
Independent Director
- Tenure: 4.1yrs
- Compensation: US$290.37k
Mike Polk (58yo)
Independent Director
- Tenure: 5.3yrs
- Compensation: US$295.37k
J.P. Bilbrey (62yo)
Independent Director
- Tenure: 4.6yrs
- Compensation: US$292.99k
Helene Gayle (63yo)
Independent Director
- Tenure: 9.6yrs
- Compensation: US$295.49k
Noel Wallace (55yo)
President
- Tenure: 0.5yrs
- Compensation: US$2.81m
Charlie Bancroft (59yo)
Independent Director
- Tenure: 2.8yrs
- Compensation: US$290.37k
Company Information
Colgate-Palmolive Company's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Colgate-Palmolive Company
- Ticker: CL
- Exchange: NYSE
- Founded: 1806
- Industry: Household Products
- Sector: Household
- Market Cap: US$58.216b
- Shares outstanding: 858.01m
- Website: https://www.colgatepalmolive.com
Number of Employees
Location
- Colgate-Palmolive Company
- 300 Park Avenue
- New York
- New York
- 10022
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CL | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Jan 1968 |
| 0P59 | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 1968 |
| CL | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Jan 1968 |
| CPA | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1968 |
| CL * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1968 |
| CPA | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Jan 1968 |
| COLG | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 1968 |
| CL | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 3 REP 1 ORD USD1 | AR | ARS | Nov 2002 | |
| COLG34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REPR 1 COM USD1 | BR | BRL | Sep 2011 |
Biography
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/16 23:35 |
| End of Day Share Price | 2019/10/16 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.